? First to represent Cerilliant® portfolio in reference standards of endogenous protein biomarkers ? Suitable for critical diagnostic testing applications by liquid chromatography, mass spectrometry Darmstadt, Germany — Merck, a leading science and technology company, today introduced the first Certified Spiking Solution® of intact, heavy labeled Thyroglobulin in SigMatrix®, a synthetic surrogate serum. The matrix-based […]
The GeneInsight-powered platform advances molecular informatics initiatives TUSCON, Ariz. – Sunquest Information Systems Inc. today announced that Nationwide Children’s Hospital Institute for Genomic Medicine Clinical Laboratory, MedComp Sciences and the University of Minnesota Health Fairview are now members of the VariantWire® data sharing initiative. GeneInsight®, a Sunquest company, supports the VariantWire networking infrastructure and crowdsourcing […]
Creates a Robust Diagnostic Platform Focused on Improving Accuracy of Cancer Diagnoses OMAHA, Neb. and NEW HAVEN, Conn. — Transgenomic, Inc. (NASDAQ: TBIO), and privately-held Precipio Diagnostics, LLC today announced entry into a merger agreement, pursuant to which Precipio will become a wholly owned subsidiary of Transgenomic, and Transgenomic will be renamed Precipio, Inc. In […]
Company Extends Ability To Deliver A Unified Sample-To-Report Software Platform For Clinical Labs PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today the acquisition of Tute Genomics, a genomics software company based in Provo, UT. The acquisition furthers PierianDx’s goal to be the most comprehensive, integrated platform to enable personalized medicine for […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced estimated third quarter revenue of approximately $607 million, a 10% increase compared to $550 million in the third quarter of 2015. This unaudited estimate, based on management’s preliminary financial analysis, is lower than the third quarter revenue guidance of $625 million to $630 million. The shortfall […]
• First next-generation sequencing platform to receive funding from BARDA • Up to $51.9 million, contract to support testing and FDA clearance of DNAe’s sequencing platform for a series of applications • Initial focus to address two of the most significant threats to global health, antimicrobial resistance and influenza London, UK and Carlsbad, CA, USA […]
GRID RNA Tumor Expression Profile analyzes genomic data points from a patient’s tumor and is available to physicians ordering Decipher Prostate Cancer Classifier tests San Diego – GenomeDx Biosciences today announced that it has launched an expanded version of its Decipher GRID® Tumor RNA Expression Profile, a report generated for prostate tumors profiled with a […]
Companies Collaborate in Their Aim to Accelerate Accurate Diagnosis of Cancer for Patients in China SANTA CLARA, Calif., and GUANGZHOU, China – Agilent Technologies Inc. (NYSE: A) and Burning Rock today announced they have signed an agreement under which Burning Rock will develop cancer diagnostics in China based on the Agilent SureSelect target enrichment system. […]
Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases MADISON, WIS – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company and the leading developer and manufacturer of induced pluripotent stem cell (iPSC) products, today announced a new venture, named Opsis Therapeutics. Formed on July 31, Opsis Therapeutics is focused […]
Genomics England is partnering with GenomOncology, LLC (GO) to utilize the GO Knowledge Management System (GO KMS) as a tool for clinical reporting enablement. Genomics England will integrate the GO KMS as a key content driver to augment clinical reporting in the 100,000 Genomes Project’s cancer programme, coupling Genomics England curated database with the GO […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
